Study TypeCognitive Impairment & Alzheimer's Disease
Study PurposeThe purpose of the rrAD research study is to assess the effects of high blood pressure on brain health. Researchers will evaluate whether exercise, blood pressure medications, or the combination of both could help reduce the risk of developing dementia in individuals with no prior dementia or Alzheimer’s diagnosis.
About the Study
Scientists at Pennington Biomedical are working to better understand the potential links between high blood pressure and the future risk for developing dementia.
The rrAD research study will enroll participants who do not currently have dementia, but who do have hypertension (high blood pressure) to assess if exercise, blood pressure medications or a combination of both treatments could reduce cognitive decline (memory loss) and reduce the future risk of developing dementia.
- 2 screening visits
- 3 introductory visits
- 3 or more weekly exercise visits (scheduled over a 2 year period)
- 4 study visits (one every 6 months for a 2 year period)
- 3 follow-up visits
- Health assessment/vital signs (blood pressure, pulse, etc.)
- Physical and neurological examinations
- Test for heart health (ECG)
- Exercise and physical performance testing
- Blood tests
- Imaging (MRI)
Total number of visits required for participants in this study:
These visits include:
- Be between the ages of 60-85 years old
- Have concerns about memory loss or have an immediate relative with a diagnosis of dementia
- Have high blood pressure or be on medication for high blood pressure
- Have a primary care physician
To qualify, participants in this study should: